Kamada KMDA
NASDAQ KMDA
$8.23 +0.03 (+0.37%)
As of: Oct 2, 2026 · 9:58 AM EDT

Kamada (KMDA) Non-Current Deffered Revenue (2012 - 2022)

Updated

Kamada's Non-Current Deffered Revenue came in at $15,000 for the quarter ended Sep 30, 2022, down 99.6% from $3.58 million a year earlier and unchanged from the prior quarter.

Analysis

Kamada (KMDA) Non-Current Deffered Revenue (2012 - 2022) Analysis & Trends

Going back to the quarter ended Jun 30, 2012, Kamada's Non-Current Deffered Revenue data covers 37 quarters.

  • Non-Current Deffered Revenue carries a five-year compound annual growth rate of -66.7% (years ended Dec 2016 to Dec 2021).
  • Going back by year, Non-Current Deffered Revenue was $2.03 million in the year ended Dec 31, 2020 (+772.8%), $232,000 in the year ended Dec 31, 2019 (-65.3%), $668,000 in the year ended Dec 31, 2018 (-5.5%) and $707,000 in the year ended Dec 31, 2017 (-80.7%).
  • The five-year range for quarterly Non-Current Deffered Revenue is $15,000 (the quarter ended Dec 31, 2021) to $3.58 million (the quarter ended Sep 30, 2021).
  • Year-over-year, Non-Current Deffered Revenue has declined for four consecutive quarters, with growth averaging 131.1% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Deffered Revenue over five years came in the quarter ended Dec 31, 2020 (growth of 772.8%), and the weakest in the quarter ended Sep 30, 2022 (a decline of 99.6%).
  • Business Quant data shows KMDA's Non-Current Deffered Revenue at $15,000 (quarter ended Jun 30, 2022), $15,000 (quarter ended Mar 31, 2022) and $15,000 (quarter ended Dec 31, 2021) in the three quarters before the quarter ended Sep 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Kamada 488.02 Mn 197.08 Mn 22.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 15,000.00
Jun 30, 2022 15,000.00
Mar 31, 2022 15,000.00
Dec 31, 2021 15,000.00
Sep 30, 2021 3.58 Mn
Jun 30, 2021 3.03 Mn
Mar 31, 2021 2.53 Mn
Dec 31, 2020 2.03 Mn
Sep 30, 2020 1.53 Mn
Jun 30, 2020 1.03 Mn
Mar 31, 2020 569,000.00
Dec 31, 2019 232,000.00
Sep 30, 2019 347,000.00
Jun 30, 2019 542,000.00
Mar 31, 2019 605,000.00
Dec 31, 2018 668,000.00
Sep 30, 2018 677,000.00
Jun 30, 2018 740,000.00
Mar 31, 2018 645,000.00
Dec 31, 2017 707,000.00
API Access

Kamada Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=KMDA&period=max&api_key=YOUR_API_KEY